Given that MYC is upregulated during blast crisis, transcriptional regulation by MYC of BCR promoter may be a crucial event in upregulation of the fusion protein and thus in the aggressiveness of CML [88,89]. The gene discussed is MYC; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.